Quality of Life for IPF Patients with New Medications

The new Idiopathic Pulmonary Fibrosis medications that were recently approved will help with treatment for patients but are not a cure for the condition.

Marily Glassberg, MD, from the University of Miami said during the recent meeting of the American College of Chest Physicians that the drugs will help in patient treatment but are not the final cure for the condition.